Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1996 Feb;70(2):1154–1162. doi: 10.1128/jvi.70.2.1154-1162.1996

Apparent uncoupling of oncogenicity from fibroblast transformation and apoptosis in a mutant myc gene transduced by feline leukemia virus.

R Fulton 1, R Gallagher 1, D Crouch 1, J C Neil 1
PMCID: PMC189924  PMID: 8551576

Abstract

The T17 v-myc oncogene was transduced by feline leukemia virus in a spontaneous feline T-cell lymphosarcoma. Molecular cloning and sequencing of the v-myc gene revealed several unique mutations, including a large deletion affecting amino acids 49 to 124 and a 3-bp insertion within the basic DNA binding domain which converts Leu-362 to Phe-Arg. The T17 lymphoma cell line was found to express a truncated 50-kDa Myc protein at exceptionally high levels, while the endogenous c-myc gene was not detectably expressed. These observations suggest that the mutant Myc product expresses an oncogenic function in T cells. Further evidence that the T17 mutant gene retains oncogenic potential was provided by its detection in clonally integrated proviruses in secondary tumors induced by feline leukemia virus T17, where no reversion mutations were found in any of three tumors examined. However, the mutant T17 v-myc gene did not induce transformation in a chicken embryo fibroblast assay, in contrast to wild-type feline c-myc, which conferred higher growth rates on the chicken fibroblasts, along with altered morphology and the ability to form foci in soft agar. Chicken cells over-expressing feline c-myc died by apoptosis when cultured with low serum concentrations, while the T17 mutant had no discernible effect. These results suggest that the leukemogenic potential of Myc can be uncoupled from its ability to cause transformation in fibroblasts. A possible explanation for this apparent paradox is that developing T cells are acutely sensitive to a subset of Myc functions which are insufficient for fibroblast transformation.

Full Text

The Full Text of this article is available as a PDF (878.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Askew D. S., Ashmun R. A., Simmons B. C., Cleveland J. L. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene. 1991 Oct;6(10):1915–1922. [PubMed] [Google Scholar]
  2. Ayer D. E., Eisenman R. N. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes Dev. 1993 Nov;7(11):2110–2119. doi: 10.1101/gad.7.11.2110. [DOI] [PubMed] [Google Scholar]
  3. Ayer D. E., Kretzner L., Eisenman R. N. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell. 1993 Jan 29;72(2):211–222. doi: 10.1016/0092-8674(93)90661-9. [DOI] [PubMed] [Google Scholar]
  4. Beijersbergen R. L., Hijmans E. M., Zhu L., Bernards R. Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation. EMBO J. 1994 Sep 1;13(17):4080–4086. doi: 10.1002/j.1460-2075.1994.tb06725.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bello-Fernandez C., Packham G., Cleveland J. L. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7804–7808. doi: 10.1073/pnas.90.16.7804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bhatia K., Huppi K., Spangler G., Siwarski D., Iyer R., Magrath I. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nat Genet. 1993 Sep;5(1):56–61. doi: 10.1038/ng0993-56. [DOI] [PubMed] [Google Scholar]
  7. Bhatia K., Spangler G., Gaidano G., Hamdy N., Dalla-Favera R., Magrath I. Mutations in the coding region of c-myc occur frequently in acquired immunodeficiency syndrome-associated lymphomas. Blood. 1994 Aug 1;84(3):883–888. [PubMed] [Google Scholar]
  8. Blackwell T. K., Kretzner L., Blackwood E. M., Eisenman R. N., Weintraub H. Sequence-specific DNA binding by the c-Myc protein. Science. 1990 Nov 23;250(4984):1149–1151. doi: 10.1126/science.2251503. [DOI] [PubMed] [Google Scholar]
  9. Blackwood E. M., Eisenman R. N. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science. 1991 Mar 8;251(4998):1211–1217. doi: 10.1126/science.2006410. [DOI] [PubMed] [Google Scholar]
  10. Bonham L., Lobelle-Rich P. A., Henderson L. A., Levy L. S. Transforming potential of a myc-containing variant of feline leukemia virus in vitro in early-passage feline cells. J Virol. 1987 Oct;61(10):3072–3081. doi: 10.1128/jvi.61.10.3072-3081.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Braun M. J., Deininger P. L., Casey J. W. Nucleotide sequence of a transduced myc gene from a defective feline leukemia provirus. J Virol. 1985 Jul;55(1):177–183. doi: 10.1128/jvi.55.1.177-183.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Crandell R. A., Fabricant C. G., Nelson-Rees W. A. Development, characterization, and viral susceptibility of a feline (Felis catus) renal cell line (CRFK). In Vitro. 1973 Nov-Dec;9(3):176–185. doi: 10.1007/BF02618435. [DOI] [PubMed] [Google Scholar]
  13. Crouch D. H., Fisher F., Clark W., Jayaraman P. S., Goding C. R., Gillespie D. A. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity. Oncogene. 1993 Jul;8(7):1849–1855. [PubMed] [Google Scholar]
  14. Crouch D. H., Lang C., Gillespie D. A. The leucine zipper domain of avian cMyc is required for transformation and autoregulation. Oncogene. 1990 May;5(5):683–689. [PubMed] [Google Scholar]
  15. Dang C. V., Lee W. M. Identification of the human c-myc protein nuclear translocation signal. Mol Cell Biol. 1988 Oct;8(10):4048–4054. doi: 10.1128/mcb.8.10.4048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Dang C. V., McGuire M., Buckmire M., Lee W. M. Involvement of the 'leucine zipper' region in the oligomerization and transforming activity of human c-myc protein. Nature. 1989 Feb 16;337(6208):664–666. doi: 10.1038/337664a0. [DOI] [PubMed] [Google Scholar]
  17. Doggett D. L., Drake A. L., Hirsch V., Rowe M. E., Stallard V., Mullins J. I. Structure, origin, and transforming activity of feline leukemia virus-myc recombinant provirus FTT. J Virol. 1989 May;63(5):2108–2117. doi: 10.1128/jvi.63.5.2108-2117.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Dong Q., Blatter E. E., Ebright Y. W., Bister K., Ebright R. H. Identification of amino acid-base contacts in the Myc-DNA complex by site-specific bromouracil mediated photocrosslinking. EMBO J. 1994 Jan 1;13(1):200–204. doi: 10.1002/j.1460-2075.1994.tb06249.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Eilers M., Schirm S., Bishop J. M. The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J. 1991 Jan;10(1):133–141. doi: 10.1002/j.1460-2075.1991.tb07929.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Enrietto P. J., Payne L. N., Hayman M. J. A recovered avian myelocytomatosis virus that induces lymphomas in chickens: pathogenic properties and their molecular basis. Cell. 1983 Dec;35(2 Pt 1):369–379. doi: 10.1016/0092-8674(83)90170-8. [DOI] [PubMed] [Google Scholar]
  21. Evan G. I., Wyllie A. H., Gilbert C. S., Littlewood T. D., Land H., Brooks M., Waters C. M., Penn L. Z., Hancock D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 1992 Apr 3;69(1):119–128. doi: 10.1016/0092-8674(92)90123-t. [DOI] [PubMed] [Google Scholar]
  22. Farina S. F., Huff J. L., Parsons J. T. Mutations within the 5' half of the avian retrovirus MC29 v-myc gene alter or abolish transformation of chicken embryo fibroblasts and macrophages. J Virol. 1992 May;66(5):2698–2708. doi: 10.1128/jvi.66.5.2698-2708.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Fisher F., Jayaraman P. S., Goding C. R. C-myc and the yeast transcription factor PHO4 share a common CACGTG-binding motif. Oncogene. 1991 Jul;6(7):1099–1104. [PubMed] [Google Scholar]
  24. Frykberg L., Graf T., Vennström B. The transforming activity of the chicken c-myc gene can be potentiated by mutations. Oncogene. 1987;1(4):415–422. [PubMed] [Google Scholar]
  25. Fuerstenberg S. M., Vennström B. Versatile avian retrovirus vectors. Anal Biochem. 1993 Mar;209(2):375–376. doi: 10.1006/abio.1993.1137. [DOI] [PubMed] [Google Scholar]
  26. Fulton R., Forrest D., McFarlane R., Onions D., Neil J. C. Retroviral transduction of T-cell antigen receptor beta-chain and myc genes. Nature. 1987 Mar 12;326(6109):190–194. doi: 10.1038/326190a0. [DOI] [PubMed] [Google Scholar]
  27. Fulton R., Plumb M., Shield L., Neil J. C. Structural diversity and nuclear protein binding sites in the long terminal repeats of feline leukemia virus. J Virol. 1990 Apr;64(4):1675–1682. doi: 10.1128/jvi.64.4.1675-1682.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Givol I., Tsarfaty I., Resau J., Rulong S., da Silva P. P., Nasioulas G., DuHadaway J., Hughes S. H., Ewert D. L. Bcl-2 expressed using a retroviral vector is localized primarily in the nuclear membrane and the endoplasmic reticulum of chicken embryo fibroblasts. Cell Growth Differ. 1994 Apr;5(4):419–429. [PubMed] [Google Scholar]
  29. Gorczyca W., Gong J., Darzynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 1993 Apr 15;53(8):1945–1951. [PubMed] [Google Scholar]
  30. Gu W., Bhatia K., Magrath I. T., Dang C. V., Dalla-Favera R. Binding and suppression of the Myc transcriptional activation domain by p107. Science. 1994 Apr 8;264(5156):251–254. doi: 10.1126/science.8146655. [DOI] [PubMed] [Google Scholar]
  31. Gupta S., Seth A., Davis R. J. Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3216–3220. doi: 10.1073/pnas.90.8.3216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Hanafusa H., Halpern C. C., Buchhagen D. L., Kawai S. Recovery of avian sarcoma virus from tumors induced by transformation-defective mutants. J Exp Med. 1977 Dec 1;146(6):1735–1747. doi: 10.1084/jem.146.6.1735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Hann S. R., King M. W., Bentley D. L., Anderson C. W., Eisenman R. N. A non-AUG translational initiation in c-myc exon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt's lymphomas. Cell. 1988 Jan 29;52(2):185–195. doi: 10.1016/0092-8674(88)90507-7. [DOI] [PubMed] [Google Scholar]
  34. Henriksson M., Bakardjiev A., Klein G., Lüscher B. Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential. Oncogene. 1993 Dec;8(12):3199–3209. [PubMed] [Google Scholar]
  35. Hughes S. H., Greenhouse J. J., Petropoulos C. J., Sutrave P. Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J Virol. 1987 Oct;61(10):3004–3012. doi: 10.1128/jvi.61.10.3004-3012.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Kato G. J., Barrett J., Villa-Garcia M., Dang C. V. An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol Cell Biol. 1990 Nov;10(11):5914–5920. doi: 10.1128/mcb.10.11.5914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. La Rocca S. A., Crouch D. H., Gillespie D. A. c-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be dissociated from cell transformation. Oncogene. 1994 Dec;9(12):3499–3508. [PubMed] [Google Scholar]
  38. Larsson L. G., Pettersson M., Oberg F., Nilsson K., Lüscher B. Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. Oncogene. 1994 Apr;9(4):1247–1252. [PubMed] [Google Scholar]
  39. Marcu K. B., Bossone S. A., Patel A. J. myc function and regulation. Annu Rev Biochem. 1992;61:809–860. doi: 10.1146/annurev.bi.61.070192.004113. [DOI] [PubMed] [Google Scholar]
  40. Martin P., Henry C., Ferre F., Duterque-Coquillaud M., Lagrou C., Ghysdael J., Debuire B., Stehelin D., Saule S. Transformation of quail embryo fibroblasts by a retrovirus carrying a normal human c-myc gene. EMBO J. 1986 Jul;5(7):1529–1533. doi: 10.1002/j.1460-2075.1986.tb04393.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Min S., Mascarenhas N. T., Taparowsky E. J. Functional analysis of the carboxy-terminal transforming region of v-Myc: binding to Max is necessary, but not sufficient, for cellular transformation. Oncogene. 1993 Oct;8(10):2691–2701. [PubMed] [Google Scholar]
  42. Neil J. C., Forrest D., Doggett D. L., Mullins J. I. The role of feline leukaemia virus in naturally occurring leukaemias. Cancer Surv. 1987;6(1):117–137. [PubMed] [Google Scholar]
  43. Neil J. C., Hughes D., McFarlane R., Wilkie N. M., Onions D. E., Lees G., Jarrett O. Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias. 1984 Apr 26-May 2Nature. 308(5962):814–820. doi: 10.1038/308814a0. [DOI] [PubMed] [Google Scholar]
  44. Penn L. J., Brooks M. W., Laufer E. M., Littlewood T. D., Morgenstern J. P., Evan G. I., Lee W. M., Land H. Domains of human c-myc protein required for autosuppression and cooperation with ras oncogenes are overlapping. Mol Cell Biol. 1990 Sep;10(9):4961–4966. doi: 10.1128/mcb.10.9.4961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Philipp A., Schneider A., Väsrik I., Finke K., Xiong Y., Beach D., Alitalo K., Eilers M. Repression of cyclin D1: a novel function of MYC. Mol Cell Biol. 1994 Jun;14(6):4032–4043. doi: 10.1128/mcb.14.6.4032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Pulverer B. J., Fisher C., Vousden K., Littlewood T., Evan G., Woodgett J. R. Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene. 1994 Jan;9(1):59–70. [PubMed] [Google Scholar]
  47. Rabbitts T. H., Hamlyn P. H., Baer R. Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma. Nature. 1983 Dec 22;306(5945):760–765. doi: 10.1038/306760a0. [DOI] [PubMed] [Google Scholar]
  48. Rickard C. G., Post J. E., Noronha F., Barr L. M. A transmissible virus-induced lymphocytic leukemia of the cat. J Natl Cancer Inst. 1969 Jun;42(6):987–1014. [PubMed] [Google Scholar]
  49. Rogers S., Wells R., Rechsteiner M. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science. 1986 Oct 17;234(4774):364–368. doi: 10.1126/science.2876518. [DOI] [PubMed] [Google Scholar]
  50. Rustgi A. K., Dyson N., Bernards R. Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature. 1991 Aug 8;352(6335):541–544. doi: 10.1038/352541a0. [DOI] [PubMed] [Google Scholar]
  51. Sanger F., Coulson A. R., Barrell B. G., Smith A. J., Roe B. A. Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing. J Mol Biol. 1980 Oct 25;143(2):161–178. doi: 10.1016/0022-2836(80)90196-5. [DOI] [PubMed] [Google Scholar]
  52. Sarid J., Halazonetis T. D., Murphy W., Leder P. Evolutionarily conserved regions of the human c-myc protein can be uncoupled from transforming activity. Proc Natl Acad Sci U S A. 1987 Jan;84(1):170–173. doi: 10.1073/pnas.84.1.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Smith D. B., Johnson K. S. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene. 1988 Jul 15;67(1):31–40. doi: 10.1016/0378-1119(88)90005-4. [DOI] [PubMed] [Google Scholar]
  54. Snyder H. W., Jr, Hardy W. D., Jr, Zuckerman E. E., Fleissner E. Characterisation of a tumour-specific antigen on the surface of feline lymphosarcoma cells. Nature. 1978 Oct 19;275(5681):656–658. doi: 10.1038/275656a0. [DOI] [PubMed] [Google Scholar]
  55. Stewart M. A., Forrest D., McFarlane R., Onions D., Wilkie N., Neil J. C. Conservation of the c-myc coding sequence in transduced feline v-myc genes. Virology. 1986 Oct 15;154(1):121–134. doi: 10.1016/0042-6822(86)90435-6. [DOI] [PubMed] [Google Scholar]
  56. Stewart T. A., Pattengale P. K., Leder P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell. 1984 Oct;38(3):627–637. doi: 10.1016/0092-8674(84)90257-5. [DOI] [PubMed] [Google Scholar]
  57. Stone J., de Lange T., Ramsay G., Jakobovits E., Bishop J. M., Varmus H., Lee W. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol Cell Biol. 1987 May;7(5):1697–1709. doi: 10.1128/mcb.7.5.1697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Terry A., Fulton R., Stewart M., Onions D. E., Neil J. C. Pathogenesis of feline leukemia virus T17: contrasting fates of helper, v-myc, and v-tcr proviruses in secondary tumors. J Virol. 1992 Jun;66(6):3538–3549. doi: 10.1128/jvi.66.6.3538-3549.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Tikhonenko A. T., Hartman A. R., Linial M. L. Overproduction of v-Myc in the nucleus and its excess over Max are not required for avian fibroblast transformation. Mol Cell Biol. 1993 Jun;13(6):3623–3631. doi: 10.1128/mcb.13.6.3623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Tsatsanis C., Fulton R., Nishigaki K., Tsujimoto H., Levy L., Terry A., Spandidos D., Onions D., Neil J. C. Genetic determinants of feline leukemia virus-induced lymphoid tumors: patterns of proviral insertion and gene rearrangement. J Virol. 1994 Dec;68(12):8296–8303. doi: 10.1128/jvi.68.12.8296-8303.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Yano T., Sander C. A., Clark H. M., Dolezal M. V., Jaffe E. S., Raffeld M. Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma. Oncogene. 1993 Oct;8(10):2741–2748. [PubMed] [Google Scholar]
  62. Zervos A. S., Gyuris J., Brent R. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell. 1993 Jan 29;72(2):223–232. doi: 10.1016/0092-8674(93)90662-a. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES